MORGAN STANLEY - ALZAMEND NEURO INC ownership

ALZAMEND NEURO INC's ticker is ALZN and the CUSIP is 02262M308. A total of 27 filers reported holding ALZAMEND NEURO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ALZAMEND NEURO INC
ValueSharesWeighting
Q3 2023$119
-53.3%
5000.0%0.00%
Q2 2023$255
-79.8%
500
-83.1%
0.00%
Q1 2023$1,261
-66.5%
2,965
-55.5%
0.00%
Q4 2022$3,765
-5.9%
6,665
+80.1%
0.00%
Q3 2022$4,000
+33.3%
3,700
-5.1%
0.00%
Q2 2022$3,000
-40.0%
3,900
+2.6%
0.00%
Q1 2022$5,000
+400.0%
3,800
+1065.6%
0.00%
Q3 2021$1,000
-50.0%
326
+25.9%
0.00%
Q2 2021$2,0002590.00%
Other shareholders
ALZAMEND NEURO INC shareholders Q3 2023
NameSharesValueWeighting ↓
RFG Advisory, LLC 250,000$59,2500.00%
TRUIST FINANCIAL CORP 2,314,907$548,6330.00%
XTX Topco Ltd 12,974$3,0750.00%
UBS Group AG 7,927$1,8790.00%
IFP Advisors, Inc 5,000$1,1850.00%
OSAIC HOLDINGS, INC. 1,000$2370.00%
FMR LLC 268$640.00%
WELLS FARGO & COMPANY/MN 495$1170.00%
NORTHERN TRUST CORP 103,775$24,5950.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALZAMEND NEURO INC shareholders